Precision BioSciences granted genetic modification patent
Research Triangle Park, N.C. —
The Research Triangle Park company announced today that the U.S. Patent and Trademark Office granted a patent related to Precision's proprietary method of producing genetically modified cells using the company's technology. Precision now says it has 13 issued genome engineering patents in the United States and one in Europe.
Precision’s proprietary Directed Nuclease Editor (DNE) technology enables the production of genome editing enzymes that can insert, remove, modify, and regulate essentially any gene in mammalian or plant cells. The technology has been used by companies in fields such as biopharmaceuticals, agricultural biotechnology and animal research.
Please log in to view WRALTechWire Insider content
Please Log In to add a comment.
Best of TechWire Insider
- NC Biotech Center braces for worst as Senate slashes budget, too
- ArchiveSocial, a new Durham success story, brings home international award
- Durham's high-tech infrastructure, talent lure Virginia company
- Lenovo acknowledges layoffs in Morrisville as part of shift to 'PC Plus' strategy
- Raleigh-based PRA International eyes public offering
- Will lightning strike again for veteran entrepreneur Brian Handly at StepLeader?
- Raleigh app developer StepLeader lands $4.4M in first fund raiser
- IBM opens Linux center in China, says it will work with Red Hat
- Red-hot Raleigh startup WedPics hauls in $1.1M in funding
- New Triangle venture capital firm slowly emerging from shadows